Page 132 - Read Online

Hum Mol Genet 2009;18:341‑6. Bacon JA, Hentati E, Williams L, Yanagiya A, Sonenberg N,
129. Tan EK, Schapira AH. Summary of GIGYF2 studies in Parkinson’s Lockhart PJ, Zubair AC, Uitti RJ, Aasly JO, Krygowska‑Wajs A,
disease: the burden of proof. Eur J Neurol 2010;17:175‑6. Opala G, Wszolek ZK, Frigerio R, Maraganore DM, Gosal D,
130. Vilariño‑Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lynch T, Hutchinson M, Bentivoglio AR, Valente EM, Nichols WC,
Lincoln SJ, Soto‑Ortolaza AI, Cobb SA, Wilhoite GJ, Bacon JA, Pankratz N, Foroud T, Gibson RA, Hentati F, Dickson DW, Destée
Behrouz B, Melrose HL, Hentati E, Puschmann A, Evans DM, A, Farrer MJ. Translation initiator EIF4G1 mutations in familial
Conibear E, Wasserman WW, Aasly JO, Burkhard PR, Djaldetti R, Parkinson disease. Am J Hum Genet 2011;89:398‑406.
Ghika J, Hentati F, Krygowska‑Wajs A, Lynch T, Melamed E, 140. Sudhaman S, Behari M, Govindappa ST, Muthane UB, Juyal RC,
Rajput A, Rajput AH, Solida A, Wu RM, Uitti RJ, Wszolek ZK, Thelma BK. VPS35 and EIF4G1 mutations are rare in Parkinson’s
Vingerhoets F, Farrer MJ. VPS35 mutations in Parkinson disease. disease among Indians. Neurobiol Aging 2013;34:2442.e1‑3.
Am J Hum Genet 2011;89:162‑7. 141. Nishioka K, Funayama M, Vilariño‑Güell C, Ogaki K, Li Y, Sasaki R,
131. Zimprich A, Benet‑Pagès A, Struhal W, Graf E, Eck SH, Offman MN, Kokubo Y, Kuzuhara S, Kachergus JM, Cobb SA, Takahashi H,
Haubenberger D, Spielberger S, Schulte EC, Lichtner P, Rossle SC, Mizuno Y, Farrer MJ, Ross OA, Hattori N. EIF4G1 gene mutations
Klopp N, Wolf E, Seppi K, Pirker W, Presslauer S, Mollenhauer B, are not a common cause of Parkinson’s disease in the Japanese
Katzenschlager R, Foki T, Hotzy C, Reinthaler E, Harutyunyan A, population. Parkinsonism Relat Disord 2014;20:659‑61.
Kralovics R, Peters A, Zimprich F, Brücke T, Poewe W, Auff E, 142. Saad M, Lesage S, Saint‑Pierre A, Corvol JC, Zelenika D,
Trenkwalder C, Rost B, Ransmayr G, Winkelmann J, Meitinger T, Lambert JC, Vidailhet M, Mellick GD, Lohmann E, Durif F, Pollak P,
Strom TM. A mutation in VPS35, encoding a subunit of the retromer Damier P, Tison F, Silburn PA, Tzourio C, Forlani S, Loriot MA,
complex, causes late‑onset Parkinson disease. Am J Hum Genet Giroud M, Helmer C, Portet F, Amouyel P, Lathrop M, Elbaz A,
2011;89:168‑75. Durr A, Martinez M, Brice A; French Parkinson’s Disease Genetics
132. Guo JF, Sun QY, Lv ZY, Yu RL, Li K, Zhang YH, Zhang YH, Tian JY, Study Group. Genome‑wide association study confirms BST1 and
Xia K, Yan XX, Tang BS. VPS35 gene variants are not associated suggests a locus on 12q24 as the risk loci for Parkinson’s disease in
with Parkinson’s disease in the mainland Chinese population. the European population. Hum Mol Genet 2011;20:615‑27.
Parkinsonism Relat Disord 2012;18:983‑5. 143. Wang C, Feng X, Xie S, Gu Z, Chan P. Exonic sequencing revealed
133. Chen Y, Chen K, Song W, Chen X, Cao B, Huang R, Zhao B, Guo X, no causative mutation in the BST1 gene in patients with Parkinson’s
Burgunder J, Li J, Shang HF. VPS35 Asp620Asn and EIF4G1 disease. Neurobiol Aging 2013;34:2695.e9‑10.
Arg1205His mutations are rare in Parkinson disease from southwest 144. Harbo HF, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S,
China. Neurobiol Aging 2013;34:1709.e7‑8. Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C,
134. Ando M, Funayama M, Li Y, Kashihara K, Murakami Y, Ishizu N, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen C,
Toyoda C, Noguchi K, Hashimoto T, Nakano N, Sasaki R, Zeviani M, Burgunder JM, Gasser T; EFNS. EFNS guidelines on
Kokubo Y, Kuzuhara S, Ogaki K, Yamashita C, Yoshino H, Hatano T, the molecular diagnosis of neurogenetic disorders: general issues,
Tomiyama H, Hattori N. VPS35 mutation in Japanese patients with Huntington’s disease, Parkinson’s disease and dystonias. Eur J
typical Parkinson’s disease. Mov Disord 2012;27:1413‑7. Neurol 2009;16:777‑85.
135. Morgan NV, Westaway SK, Morton JE, Gregory A, Gissen P, Sonek S, 145. Marek K, Jennings D, Tamagnan G, Seibyl J. Biomarkers for
Cangul H, Coryell J, Canham N, Nardocci N, Zorzi G, Pasha S, Parkinson’s [corrected] disease: tools to assess Parkinson’s disease
Rodriguez D, Desguerre I, Mubaidin A, Bertini E, Trembath RC, onset and progression. Ann Neurol 2008;64 Suppl 2:S111‑21.
Simonati A, Schanen C, Johnson CA, Levinson B, Woods CG, 146. Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T,
Wilmot B, Kramer P, Gitschier J, Maher ER, Hayflick SJ. PLA2G6, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK,
encoding a phospholipase A2, is mutated in neurodegenerative Litvan I. Neuropathological assessment of Parkinson’s disease:
disorders with high brain iron. Nat Genet 2006;38:752‑4. refining the diagnostic criteria. Lancet Neurol 2009;8:1150‑7.
136. Paisan‑Ruiz C, Bhatia KP, Li A, Hernandez D, Davis M, Wood NW, 147. Forman MS, Lee VM, Trojanowski JQ. Nosology of Parkinson’s
Hardy J, Houlden H, Singleton A, Schneider SA. Characterization disease: looking for the way out of a quagmire. Neuron
of PLA2G6 as a locus for dystonia‑parkinsonism. Ann Neurol 2005;47:479‑82.
2009;65:19‑23. 148. Wang C, Cai Y, Gu Z, Ma J, Zheng Z, Tang BS, Xu Y, Zhou Y, Feng T,
137. Tomiyama H, Yoshino H, Ogaki K, Li L, Yamashita C, Li Y, Wang T, Chen SD, Chan P; Chinese Parkinson Study Group. Clinical
Funayama M, Sasaki R, Kokubo Y, Kuzuhara S, Hattori N. PLA2G6 profiles of Parkinson’s disease associated with common leucine‑rich
variant in Parkinson’s disease. J Hum Genet 2011;56:401‑3. repeat kinase 2 and glucocerebrosidase genetic variants in Chinese
138. Lv Z, Guo J, Sun Q, Li K, Yu R, Tian J, Yan X, Tang B. Association individuals. Neurobiol Aging 2014;35:725.e1‑6.
between PLA2G6 gene polymorphisms and Parkinson’s disease
in the Chinese Han population. Parkinsonism Relat Disord
2012;18:641‑4.
139. Chartier‑Harlin MC, Dachsel JC, Vilariño‑Güell C, Lincoln SJ, Cite this article as: Wang CD, Chan P. Clinicogenetics of Parkinson’s disease:
a drawing but not completed picture. Neuroimmunol Neuroinflammation
Leprêtre F, Hulihan MM, Kachergus J, Milnerwood AJ, 2014;1(3):115-26.
Tapia L, Song MS, Le Rhun E, Mutez E, Larvor L, Duflot A, Source of Support: Nil. Conflict of Interest: No.
Vanbesien‑Mailliot C, Kreisler A, Ross OA, Nishioka K,
Soto‑Ortolaza AI, Cobb SA, Melrose HL, Behrouz B, Keeling BH, Received: 15-07-2014; Accepted: 05-09-2014

126 Neuroimmunol Neuroinflammation | Volume 1 | Issue 3 | December 2014